Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion

Springer Science and Business Media LLC - Tập 17 - Trang 87-92 - 1995
A. R. Barnes1, S. Nash2
1Pharmaceutical Sciences Institute, Aston University, Birmingham, UK
2Regional Quality Control Laboratory, City Hospital, Birmingham, UK

Tóm tắt

The stability of diamorphine (0.02 mg/ml as the hydrochloride) in 250 ml bupivacaine hydrochloride (0.15% wt/vol infusion) was studied by high pressure liquid chromatography at temperatures in the range 7 to 45°C. Diamorphine hydrochloride was degraded by approximately 0.13% per day at 7°C. No bupivacaine hydrochloride degradation was detectable during the study. The storage life of the combination at 7°C, based on the lower 95% confidence limit of the time to 5% diamorphine hydrochloride degradation, was 14 days. The stability at 25°C was adequate to allow transport and administration over 24 h at ambient temperature. Stability was also maintained for at least 24 h at 32 and 45°C. Infusion of the mixture with an ambulatory infusion pump which uses a standard polyvinyl chloride infusion bag is therefore possible. A study of its compatibility with different infusion pump medication reservoirs was not undertaken. The drugs were also stable on frozen storage at −18°C for up to 6 months.

Tài liệu tham khảo

Lee A, Simpson D, Whitfield A, Scott DB. Postoperative analgesia by continuous extradural infusion of bupivacaine and diamorphine. Br J Anaesth 1988;60:845–50. Hobbs GJ, Roberts FL. Epidural infusion of bupivacaine and diamorphine for postoperative analgesia. Use on general surgical wards. Anaesthesia 1992;47:58–62. Carstensen JT. Drug stability: principles and practices. New York: Marcel Dekker, 1990:209–61. Beaumont I, Deeks T. Determination of morphine, diamorphine and their degradation products in pharmaceutical preparations by reversed-phase high-performance liquid chromatography. J Chromatogr 1982;238:520–4. Gröningsson K, Lindgren J-E, Lundberg E, Sandberg R, Wahlén A. Lidocaine base and hydrochloride, In: Florey K, editor. Analytical profiles of drug substances. Vol. 14. Orlando: Academic Press, 1985:207–43. British Pharmacopoeia 1993, Vol. II, London: HMSO, 1993:873. Poochikian GK, Cradock JC. Stability of Brompton mixtures: determination of heroin (diacetylmorphine) and cocaine in the presence of their hydrolysis products. J Pharm Sci 1980;69:637–9. Beaumont IM. Stability study of aqueous solutions of diamorphine and morphine using HPLC. Pharm J 1982;229:39–41. Cooper H, Mehta AC, Calvert RA. Stability of diamorphine in chloroform-water mixture. Pharm J 1981;226:682–3. Collins AJ, Abethell JA, Holmes SG, Bain R. Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration. J Pharm Pharmacol 1986;38(Suppl):51P. Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, et al. Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. Am J Hosp Pharm 1990;47:377–81. Omar OA, Hoskin PJ, Johnston A, Hanks GW, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion. J Pharm Pharmacol 1989;41:275–7. Allwood MC. The stability of diamorphine alone and in combination with anti-emetics in plastic syringes. Palliative Med 1991;5:330–3. Northcott M, Allsopp MA, Powell H, Sewell GJ. The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged ‘in-use’ conditions. J Clin Pharm Ther 1991; 16:123–9. Barrett DA, Dyssegaard ALP, Shaw PN. The effect of temperature and pH on the deacetylation of diamorphine in aqueous solution and in human plasma. J Pharm Pharmacol 1992;44:606–8. Jones JW, Davis AT. Stability of bupivacaine hydrochloride in polypropylene syringes. Am J Hosp Pharm 1993;50:2364–5. Alford AM, Peacock JE, Henderson P, Middleton M. Stability and variability of fentanyl citrate, bupivacaine hydrochloride and a mixture of the two drugs in 500 ml infusion bags. Hosp Pharm Pract 1992;2:529–31. Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK. Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion. Br J Anaesth 1992;68:414–7. Lohman JJHM, Janssen MJ, Cilissen J, Hendriks MWG, Hooymans PM, Janknegt R. Compatibility of morphine hydrochloride and bupivacaine hydrochloride in a portable pump reservoir [abstract]. Pharm Weekbl Sci 1992;14(Suppl F):F27. Tu Y-H, Stiles ML, Allen LV. Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs. Am J Hosp Pharm 1990;47:2037–40. Roos PJ, Glerum JH, Schroeders MJH. Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter. Pharm World Sci 1993;15:269–75. Poochikian GK, Cradock JC. Simple high-performance liquid Chromatographic method for the separation of 3,6-diacetylmorphine hydrochloride (heroin) and hydrolysis products. J Chromatogr 1979;171:371–6. Etches RC, Sandler AN, Daley MD. Respiratory depression and spinal opioids. Can J Anaesth 1989;36:165–85.